Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01482962
Brief Title: Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma

First Submitted : November 28, 2011
First Submitted that Met QC Criteria : November 30, 2011
First Posted : December 1, 2011 (Estimate)

Results First Submitted : May 9, 2018
Results First Submitted that Met QC Criteria : July 6, 2018
Results First Posted : July 31, 2018

Last Update Submitted that Met QC Criteria : July 6, 2018
Last Update Posted : July 31, 2018